DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up
Quest Diagnostics Incorporated’s DGX third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted figure by 3.
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS. Read why I remain bullish on DGX stock.
Quest Diagnostics: Q3 Earnings Snapshot
SECAUCUS, N.J. (AP) — SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. (DGX) on Tuesday reported third-quarter earnings of $226 million. On a per-share basis, the Secaucus, New Jersey-based company said it had net income of $1.99. Earnings, adjusted for one-time gains and costs, were $2.30 per share.
Quest Diagnostics beats quarterly results estimates on diagnostic test demand
Laboratory operator Quest Diagnostics beat Wall Street estimates for third-quarter profit and revenue on Tuesday, helped by robust demand for its diagnostic tests. Demand for diagnostic checkups has grown in recent quarters as more people,
Quest Diagnostics EPS Beats Expectations
Quest Diagnostics reported strong third-quarter earnings driven by acquisitions, with revenue surpassing expectations, though profit margins faced pressure.
Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates
Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.22 per share a year ago. These figures are adjusted for non-recurring items.
Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base
Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, and offers 2.0% dividend yield.
Fintel on MSN1d
Baird Upgrades Quest Diagnostics (DGX)
Fintel reports that on October 23, 2024, Baird upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Neutral to ...
Quest Diagnostics (DGX) Receives a Hold from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Hold rating on Quest Diagnostics (DGX – Research ...
bovnews5d
Quest Diagnostics Inc (DGX) Stock: Surpassing Expectations in the Market?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.49% of ...
news.stocktradersdaily6d
When (DGX) Moves Investors should Listen
Check the time stamp on this data. Updated AI-Generated Signals for Quest Diagnostics Incorporated (DGX) available here: DGX.
Quest Diagnostics awarded several contracts by CDC
Quest Diagnostics (DGX) announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention, or CDC, to ...
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. cut its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.0% during the 3rd quarter ...
Datacenter Dynamics10d
University of Albany unveils new Nvidia DGX-powered AI supercomputer
The University of Albany (UAlbany) in New York has unveiled a new AI supercomputer. UAlbany said the system is one of the ...
Business Insider2d
Quest Revises Annual Outlook To Reflect Acquisitions, Expects Hurricane Impact In Q4
(RTTNews) - Quest Diagnostics Inc. (DGX), a provider of medical diagnostic services, on Tuesday revised its annual outlook to reflect the impact of recent acquisitions, including LifeLabs. For the ...
1,353 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Clarius Group LLC
Clarius Group LLC bought a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) in the third quarter, according to the company in its most recent 13F filing with the ...